ZA9811621B - Novel sterilization process for pharmaceutical suspensions - Google Patents

Novel sterilization process for pharmaceutical suspensions

Info

Publication number
ZA9811621B
ZA9811621B ZA9811621A ZA9811621A ZA9811621B ZA 9811621 B ZA9811621 B ZA 9811621B ZA 9811621 A ZA9811621 A ZA 9811621A ZA 9811621 A ZA9811621 A ZA 9811621A ZA 9811621 B ZA9811621 B ZA 9811621B
Authority
ZA
South Africa
Prior art keywords
sterilization process
pharmaceutical suspensions
novel sterilization
novel
suspensions
Prior art date
Application number
ZA9811621A
Other languages
English (en)
Inventor
Shivaji Purwar
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA9811621B publication Critical patent/ZA9811621B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicinal Preparation (AREA)
ZA9811621A 1997-12-19 1998-12-18 Novel sterilization process for pharmaceutical suspensions ZA9811621B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/994,626 US6066292A (en) 1997-12-19 1997-12-19 Sterilization process for pharmaceutical suspensions

Publications (1)

Publication Number Publication Date
ZA9811621B true ZA9811621B (en) 1999-06-23

Family

ID=25540864

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9811621A ZA9811621B (en) 1997-12-19 1998-12-18 Novel sterilization process for pharmaceutical suspensions

Country Status (10)

Country Link
US (1) US6066292A (fr)
EP (1) EP1039937A2 (fr)
JP (1) JP2001526089A (fr)
KR (1) KR20010033306A (fr)
CN (1) CN1282256A (fr)
AU (1) AU730621B2 (fr)
CA (1) CA2310698A1 (fr)
IL (1) IL135959A0 (fr)
WO (1) WO1999032156A2 (fr)
ZA (1) ZA9811621B (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
MXPA01004381A (es) * 1998-11-02 2005-09-08 Elan Corp Plc Composicion de multiparticulado de liberacion modificada.
US20090297602A1 (en) * 1998-11-02 2009-12-03 Devane John G Modified Release Loxoprofen Compositions
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
BR0115584A (pt) 2000-11-24 2003-09-23 Breath Ltd Esterilização de produtos farmacêuticos
US6884436B2 (en) 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6951656B2 (en) 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US7037528B2 (en) 2000-12-22 2006-05-02 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US6977085B2 (en) 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
BR0212833A (pt) 2001-09-26 2004-10-13 Baxter Int Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
EP3513813A1 (fr) * 2002-07-02 2019-07-24 Astrazeneca Suspension aqueuse stérile contenant du ciclésonide
EP1556091A1 (fr) * 2002-10-04 2005-07-27 Elan Pharma International Limited Irradiation gamma d'agents actifs nanoparticulaires solides
AU2003301129A1 (en) * 2002-12-20 2004-07-22 Control Delivery Systems, Inc. Steroid compositions for intraocular use
EP1454636A1 (fr) * 2003-03-04 2004-09-08 Dompé S.P.A. Stérilisation de médicaments glucocorticostéroides particulaires pour application pulmonaire
EP1626742A1 (fr) * 2003-05-22 2006-02-22 Elan Pharma International Limited Sterilisation de dispersions d'agents actifs particulaires au moyen de rayons gamma
ITMI20032054A1 (it) 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
GB0410995D0 (en) * 2004-05-17 2004-06-23 Norton Healthcare Ltd Heat sterilization of glucocorticosteroids
US20060094700A1 (en) * 2004-11-02 2006-05-04 Allergan, Inc. Heat sterilization of a steroid in the presence of phosphate
CN101106972A (zh) * 2004-11-16 2008-01-16 伊兰制药国际有限公司 注射用纳米微粒奥氮平制剂
GB0425266D0 (en) * 2004-11-16 2004-12-15 Norton Healthcare Ltd Pharmaceutical manufacturing process
EP1855651A4 (fr) * 2005-03-03 2011-06-15 Elan Pharma Int Ltd Compositions nanoparticulaires de derives d'amide heterocyclique
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20070178051A1 (en) * 2006-01-27 2007-08-02 Elan Pharma International, Ltd. Sterilized nanoparticulate glucocorticosteroid formulations
AU2007272501A1 (en) * 2006-07-12 2008-01-17 Elan Pharma International Limited Nanoparticulate formulations of modafinil
US8865692B2 (en) 2007-11-13 2014-10-21 Meritage Pharma, Inc Compositions for the treatment of gastrointestinal inflammation
US20090149433A1 (en) 2007-11-13 2009-06-11 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
HUE051538T2 (hu) * 2008-08-20 2021-03-01 Univ California Kortikoszteroidok a gyomor-bél traktus gyulladásos betegségeinek kezelésére
GR20090100230A (el) * 2009-04-14 2010-11-18 Casso Pharmaceuticals Ε.Π.Ε, Απο του στοματος εναιωρημα οξικης δεξαμεθανοζης-συνθεση καλυψης γευσης της δεξαμεθανοζης
US8273725B2 (en) * 2009-09-10 2012-09-25 Genzyme Corporation Stable hyaluronan/steroid formulation
TWI577377B (zh) * 2010-09-16 2017-04-11 Ｖｉｉｖ醫療保健公司 醫藥組合物
JP5809803B2 (ja) * 2011-01-11 2015-11-11 岩井機械工業株式会社 液体製品の調合製造方法
BR112014013564A8 (pt) * 2011-12-09 2017-06-13 Lupin Ltd composição farmacêutica tópica destinada à aplicação ao olho, ouvido ou nariz
US10111956B2 (en) 2013-06-03 2018-10-30 Tolmar, Inc. Corticosteroid compositions
WO2016004231A1 (fr) 2014-07-03 2016-01-07 Otonomy, Inc. Stérilisation d'une composition de ciprofloxacine
US10729663B1 (en) * 2015-08-21 2020-08-04 University Of South Florida Nanoparticles in thermoreversible gels for enhanced therapeutics
EP3784296B1 (fr) * 2018-04-24 2024-04-10 Pierre Fabre Dermo-Cosmétique Procédé et dispositif pour la fabrication d'une émulsion dermo-cosmétique stérile comprenant un gélifiant
FR3080287B1 (fr) * 2018-04-24 2023-09-22 Fabre Pierre Dermo Cosmetique Procede et dispositif pour la fabrication d'une emulsion dermo cosmetique sterile
CN109529065A (zh) * 2018-12-27 2019-03-29 湖北远大天天明制药有限公司 一种卡波姆分散灭菌方法及其应用
CN113289041B (zh) * 2021-05-11 2023-05-23 广东稳健药业有限公司 一种润肠药剂生产设备及生产工艺
WO2023136788A1 (fr) * 2022-01-17 2023-07-20 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Procédé de préparation d'une suspension homogène stérile pour inhalation par nébulisation
CN119607237A (zh) * 2025-02-13 2025-03-14 坛墨质检科技股份有限公司 一种水基质标准物的除菌抑菌方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962430A (en) * 1974-08-07 1976-06-08 Merck & Co., Inc. Sterilization of solid non-electrolyte medicinal agents employing sodium chloride
US5536413A (en) * 1990-12-03 1996-07-16 Pall Corporation Method for treating a parenteral emulsion-containing medicament fluid

Also Published As

Publication number Publication date
KR20010033306A (ko) 2001-04-25
CA2310698A1 (fr) 1999-07-01
EP1039937A2 (fr) 2000-10-04
US6066292A (en) 2000-05-23
WO1999032156A2 (fr) 1999-07-01
WO1999032156A3 (fr) 1999-09-10
JP2001526089A (ja) 2001-12-18
AU730621B2 (en) 2001-03-08
AU1630199A (en) 1999-07-12
IL135959A0 (en) 2001-05-20
CN1282256A (zh) 2001-01-31

Similar Documents

Publication Publication Date Title
IL135959A0 (en) Novel sterilization process for pharmaceutical suspensions
GB9726563D0 (en) Novel pharmaceutical
EG22337A (en) Process for preparing novel pharmaceutical compounds
HUP0000538A3 (en) Process for disinfecting instruments
EG23694A (en) Novel pharmaceutical
HU9802180D0 (en) Process for producing pharmaceutical compositions
IL118590A (en) Pharmaceutical composition for minimizing bone loss
IL117397A0 (en) Novel naphthyl pharmaceutical compounds
EP0986389A4 (fr) Nouveau procede
HU9800396D0 (en) Pharmaceutical composition for treating dementia
IL134059A0 (en) Process for preparing aminoarylacetylenes
IL131205A0 (en) Process for preparing pharmaceutical compounds
EG23935A (en) Process for preparing eprosartin
GB9700690D0 (en) Novel process
IL126184A0 (en) Process for preparing pentafluoropentanol
AU5935498A (en) Process for sterilizing beverages
HU9701137D0 (en) Process for producing pharmaceutical intermedier
ZA9811499B (en) Process for reparing chlorobenzoxazoles
IL133288A (en) Process for preparing 3-isochromanone
GB9706376D0 (en) Novel pharmaceutical
KR200160082Y1 (en) Sterilization dish-drying
GB2322785B (en) Pasteurizing process
IL125646A (en) Process for preparing N-pyruvyl-L-proline
HU9801024D0 (en) Process for producing pharmaceutical intermediate
MD810F1 (en) Process for modified ionites obtaining